Managers

Scale’s Kate Mitchell on generational transition and managing carried interest

Monthly recap of fund briefs, as of June 21

Matrix Partners China raises $750 mln for fifth venture-capital fund

Matrix Partners China has raised $750 million for a fifth venture-capital fund, according to a filing with the SEC.

World Innovation Lab collects $521 mln for second fund

World Innovation Lab has raised $521 million for its second fund, according to an SEC filing. The Palo Alto, California-based venture firm invests in consumer and enterprise technology companies.

VC-backed Avrobio rolls out IPO

Cambridge, Massachusetts-based Avrobio, a developer of gene therapies for rare diseases, has raised $99.7 million for its IPO after pricing its over 5.2 million shares at $19 per share. The stock began trading June 21, 2018 on the NASDAQ under the ticker symbol "AVRO." Morgan Stanley, Cowen and Wells Fargo Securities are the lead underwriters. Avrobio's pre-IPO backers include Cormorant Asset Management, Surveyor Capital, Aisling, Brace Pharma Capital, Eventide Asset Management, Morningside, Atlas Venture, SV Health Investors and Clarus Ventures.

VC-backed Aptinyx goes public

Aptinyx Inc, a biopharmaceutical company focused on developing treatments for neurologic disorders, has debuted its IPO after pricing its near 6.4 million shares at $16 per share. The stock began trading June 21, 2018 on the NASDAQ under the ticker symbol "APTX." J.P. Morgan, Cowen, Leerink Partners and BMO Capital Markets are the lead underwriters. Aptinyx's pre-IPO backers include Bain Capital Life Sciences, Adage Capital, Nan Fung Life Sciences, Rock Springs Capital, New Leaf Venture Partners, Frazier Healthcare Partners, Osage University Partners, Adams Street Partners and Beecken Petty O’Keefe & Company.

Free award-winning stories from Buyouts and VCJ

VCs on the Move monthly recap, as of June 20

Sequoia Capital to raise six venture and growth funds in U.S., China, India

Sequoia Capital filed with the Securities and Exchange Commission to raise six venture-capital and growth funds in the United States, China and India, the filings show.

Jerusalem Venture Partners raises $168.4 mln for eighth venture-capital fund

Jerusalem Venture Partners has raised $168.4 million toward a $200 million eighth venture-capital fund, according to a filing with the SEC.